This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Cockshott, A Articles by Basketter, D A Search for Related Content PubMed PubMed Citation Articles by Cockshott, A Articles by Basketter, D A Social Bookmarking                         What's this?

The local lymph node assay in practice: a current regulatory perspective

Health and Safety Executive, Redgrave Court, Merton Road, Bootle, Merseyside, L20 7HS, UKamanda.cockshott{at}hse.gsi.gov.uk

P Evans

Health and Safety Executive, Bootle, UK

C A Ryan

G F Gerberick

Procter & Gamble, Cincinnati, OH, USA

C J Betts

R J Dearman

I Kimber

Syngenta Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire, UK

D A Basketter

Unilever Safety and Environmental Assurance Centre, Colworth House, Sharnbrook, Bedfordshire, UK

Following the formal acceptance of the local lymph node assay (LLNA) as an Organization for Economic Cooperation and Development (OECD) guideline in April 2002, the UK Health and Safety Executive (HSE) informed notifiers that this was now the method of choice for the assessment of skin sensitization potential under the EU notification scheme for new industrial chemicals (NONS). This paper summarizes the experience of the HSE for the 2-year period immediately following the issuing of this statement, during which 48 LLNA study reports were assessed for notification purposes. The issues discussed here include adherence to the OECD guideline, interpretation of results, and classification outcomes. Generally, notifying laboratories followed the OECD guideline successfully, with regard to the sex/ strain/numbers of mice used, the precise process used for measurement of cell proliferation, and the use of recommended vehicles and positive controls. Initially, use of the individual animal approach (measuring the cell proliferation in each animal rather than for a pooled dose group) highlighted problems caused by technical inexperience, but these were overcome by practice. Toxicity or irritation were found to be minor factors in dose selection; more important was the choice of vehicle to correctly maximize the test substance concentration, while maintaining appropriate application properties. Contrary to concerns that the LLNA would prove to be less sensitive or more sensitive than the traditionally used Guinea Pig Maximization Test (GPMT), the proportion of new substances classified as skin sensitizers was within the range observed in previous years. Although the sample size is relatively small, the experience of the HSE indicates that the LLNA is satisfactory for routine regulatory use.

Key Words: hazard identification • local lymph node assay • skin sensitization

Human & Experimental Toxicology, Vol. 25, No. 7, 387-394 (2006)
DOI: 10.1191/0960327106ht640oa


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				D. R. Boverhof, B. B. Gollapudi, J. A. Hotchkiss, M. Osterloh-Quiroz, and M. R. Woolhiser Evaluation of a toxicogenomic approach to the local lymph node assay (LLNA) Toxicol. Sci., February 1, 2009; 107(2): 427 - 439. [Abstract] [Full Text] [PDF]

				D. R. Boverhof, C. M. Wiescinski, P. Botham, D. Lees, E. Debruyne, M. Repetto-Larsay, G. Ladics, D. Hoban, A. Gamer, M. Remmele, et al. Interlaboratory Validation of 1% Pluronic L92 Surfactant as a Suitable, Aqueous Vehicle for Testing Pesticide Formulations Using the Murine Local Lymph Node Assay Toxicol. Sci., September 1, 2008; 105(1): 79 - 85. [Abstract] [Full Text] [PDF]

				G. F. Gerberick, J. D. Vassallo, L. M. Foertsch, B. B. Price, J. G. Chaney, and J.-P. Lepoittevin Quantification of Chemical Peptide Reactivity for Screening Contact Allergens: A Classification Tree Model Approach Toxicol. Sci., June 1, 2007; 97(2): 417 - 427. [Abstract] [Full Text] [PDF]